Edgar Snyder & Associates®
A Law Firm Representing Injured People
1-866-943-3427
Call Us Toll Free 24/7
Published on Jan 10, 2006 by Edgar Snyder

Fourth Vioxx Trial Nears for Merck

Vioxx Trial

The fourth Vioxx battle for Merck & Co. is slated to begin in late January. The case involves a 71-yr-old man, Leonel Garza, who died after taking Vioxx for one month.

The attorneys acting on behalf of Mr. Garza’s family believe this is a “very strong” case despite his various cardiovascular complications and history of heart problems. Prior to the heart attack that killed Mr. Garza in 2001, he underwent an operation to open his clogged arteries. A scan taken a few weeks before his heart attack showed normal blood flow to the area where Mr. Garza once had clots. Doctors recorded Mr. Garza’s condition as “stable” in his medical files. Merck maintains that Mr. Garza’s short term use of Vioxx could not have been the cause of his deadly heart attack.

Vioxx was taken off the market in 2004 after it was associated with increases in heart-attack risks.

For more information about Vioxx, visit our Vioxx Legal Center.

Please note: All of our lawyers are licensed to practice in the state of Pennsylvania. We also have lawyers licensed to practice in Ohio, and West Virginia and we associate with experienced attorneys in other states. In addition, all drug-related litigation involves co-counsel.

Source; “Merck Faces Fourth Vioxx Trial in Case of Heart-Attack Death.” By Heather Won Tesoriero. The Wall Street Journal. January 10, 2006.
Think you have a case?
Think you have a case?
Free Case Review
First Name
Last Name
ZIP
Phone
Email
Briefly describe your injuries

Recent News

Sep 30, 2016
September Mocktail: Apple Pie Punch
Sep 28, 2016
Pittsburgh Police Beefing Up DUI Patrols in 2017
Sep 26, 2016
Gear Up, Cool Down, and Stay Safe While Riding This Fall
Sep 16, 2016
Fall and Winter Car Kit
Sep 16, 2016
A New Law May Be Coming for Drivers
Tweet